Clinical Trials in Phoenix

Showing 11101-11120 of 14,291 trials

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

NCT01672164

The main focus of this study is to develop blood and/or urine tests that will help to detect early signs of rejection in people who have had a liver transplant. Researchers will examine blood, urine, and tissue samples and try to identify markers for certain conditions such as rejection, response to therapy, and scarring of the liver. Additionally, researchers would like to identify biomarkers that can detect damage to the native kidneys before blood levels of creatinine rises. By studying gene expression, researchers hope to be able to diagnose these conditions earlier and improve liver survival.

Liver Transplant RecipientsLiver Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)202 participantsStarted Aug 2012

Phoenix, Arizona, United States • Chicago, Illinois, United States • New York, New York, United States +3 more locations

TERMINATEDPhase 2< 1 mile

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

NCT01838499

The purpose of this study is to gain initial evidence for the safety, tolerability and efficacy of MEDI8968 for the treatment of subjects with moderate to severe hidradenitis suppurativa

Hidradenitis Suppurativa

AstraZeneca224 participantsStarted May 2013

Phoenix, Arizona, United States • Bakersfield, California, United States • Fremont, California, United States +24 more locations

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Find Trials by Condition in Phoenix

Bipolar Study in Adults at Least 18 Years of Age

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Drug Interaction Study of MGL-3196 With Atorvastatin

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Sensor Optimization of Cardiac Resynchronization Therapy Response